Alcohol consumption and rectal tumor mutations and epigenetic changes

Diseases of the Colon and Rectum

Volumn 53, Issue 8, 2010, Pages 1182-1189

  Slattery, Martha L ^a   Wolff, Roger K ^a   Herrick, Jennifer S ^a   Curtin, Karen ^a   Caan, Bette J ^b   Samowitz, Wade ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Alcohol; Beer; CpG Island Methylator Phenotype; KRAS2; Rectal cancer; TP53; Wine

Indexed keywords

K RAS PROTEIN; PROTEIN P53; TUMOR MARKER; DNA; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; TP53 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEER; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; RECTUM CANCER; RECTUM TUMOR; RISK REDUCTION; BIOPSY; CLINICAL TRIAL; COMPARATIVE STUDY; DRINKING BEHAVIOR; FOLLOW UP; GENETIC EPIGENESIS; GENETICS; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TIME; UNITED STATES;

ADULT; AGED; ALCOHOL DRINKING; BIOPSY; CALIFORNIA; CPG ISLANDS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UTAH;

EID: 77956199404     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181d325db     Document Type: Article

References (43)

1. Bongaerts BW, van den Brandt PA, Goldbohm RA, de Goeij AF, Weijenberg MP. Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. Int J Cancer. 2008;123:2411-2417.
2. Akhter M, Kuriyama S, Nakaya N, et al. Alcohol consumption is associated with an increased risk of distal colon and rectal cancer in Japanese men: The Miyagi Cohort Study. Eur J Cancer. 2007; 43:383-390.
3. Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: A dose-response meta-analysis of published cohort studies. Int J Cancer. 2007;120:664-671.
4. Pedersen A, Johansen C, Gronbaek M. Relations between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut. 2003;52:861-867.
5. Bongaerts BW, de Goeij AF, van den Brandt PA, Weijenberg MP. Alcohol and the risk of colon and rectal cancer with mutations in the K-ras gene. Alcohol. 2006;38:147-154.
6. Slattery ML, Curtin K, Sweeney C, et al. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer. 2007;120:656-663.
7. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D, Samowitz W. Dietary intake and microsatellite instability in colon tumors. Int J Cancer. 2001;93:601-607.
8. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer: beyond physical activity. Cancer Res. 1997;57:75-80.
9. Samowitz WS, Curtin K, Schaffer D, Robertson M, Leppert M, Slattery ML. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: A population-based study. Cancer Epidemiol Biomarkers Prev. 2000;9:1193-1197.
10. Slattery ML, Curtin K, Ma K, et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev. 2002;11:541-548.
11. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-845.
12. Samowitz WS, Albertsen H, Sweeney C, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst. 2006;98:1731-1738.
13. Issa JP, Shen L, Toyota M. CIMP, at last. Gastroenterology. 2005; 129:1121-1124.
14. Edwards S, Slattery ML, Mori M, et al. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol. 1994;140:1020-1028.
15. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, Kerber R. A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc. 1994;94:761-766.
16. McDonald A, Van Horn L, Slattery M, et al. The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc. 1991;91:1104-1112.
17. Liu K, Slattery M, Jacobs D Jr, et al. A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis. 1994;4:15-27.
18. Slattery ML, Curtin K, Anderson K, et al. Associations between dietary intake and Ki-ras mutations in colon tumors: A population- based study. Cancer Res. 2000;60:6935-6941.
19. Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modelling. Stat Med. 1998;17:1261-1291.
20. Kuss O, McLerran D. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Meth Programs Biomed. 2007;87:262-269.
21. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Wilkinson G. Lifetime alcohol intake and risk of rectal cancer in western New York. Nutr Cancer. 1990;13:101-109. (Pubitemid 20274642)
22. Tavani A, Ferraroni M, Mezzetti M, Franceschi S, Lo Re A, La Vecchia C. Alcohol intake and risk of cancers of the colon and rectum. Nutr Cancer. 1998;30:213-219.
23. Gerhardsson de Verdier M, Romelsjo A, Lundberg M. Alcohol and cancer of the colon and rectum. Eur J Cancer Prev. 1993;2: 401-408.
24. Hu JF, Liu YY, Yu YK, Zhao TZ, Liu SD, Wang QQ. Diet and cancer of the colon and rectum: A case-control study in China. Int J Epidemiol. 1991;20:362-367.
25. Ferrari P, Jenab M, Norat T, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007;121:2065-2072. (Pubitemid 47463172)
26. Slattery ML, Curtin K, Wolff RK, et al. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum. 2009;52: 1304-1311.
27. Marsit CJ, Christensen BC, Houseman EA, et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis. 2009;30:416-422.
28. Paixao N, Pereira V, Marques JC, Camara JS. Quantification of polyphenols with potential antioxidant properties in wines using reverse phase HPLC. J Separation Sci. 2008;31:2189-2198.
29. Seeram NP, Aviram M, Zhang Y, et al. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J Agric Food Chem. 2008;56:1415-1422.
30. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA. 2003;100:143-148.
31. Hussain SP, Harris CC. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res. 1999;428:23-32.
32. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994;265:346-355.
33. Shen YM, Troxel AB, Vedantam S, Penning TM, Field J. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: Role of reactive oxygen and biological selection. Chem Res Toxicol. 2006;19:1441-1450.
34. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J. 2003;17: 1195-1214. (Pubitemid 36775767)
35. Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome. Oncogene. 2006;25:677-684.
36. Wink DA, Hanbauer I, Grisham MB, et al. Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms. Curr Top Cell Regul. 1996;34:159-187.
37. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer- prone chronic inflammatory disease. Cancer Res. 2000;60: 3333-3337.
38. Yajima H, Ikeshima E, Shiraki M, et al. Isohumulones, bitter acids derived from hops, activate both peroxisome proliferatoractivated receptor alpha and gamma and reduce insulin resistance. J Biol Chem. 2004;279:33456-33462.
39. Kondo K. Beer and health: preventive effects of beer components on lifestyle-related diseases. BioFactors (Oxford). 2004;22: 303-310.
40. Nozawa H, Tazumi K, Sato K, et al. Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon. Mutat Res. 2004;559:177-187.
41. Nozawa H, Yoshida A, Tajima O, et al. Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fischer 344 rats. Int J Cancer. 2004;108:404-411.
42. Beer drinking and the risk of rectal cancer. Nutr Rev. 1984;42: 244-247.
43. Edwards SL, Slattery ML, Ma KN. Measurement errors stemming from nonrespondents present at in-person interviews. Ann Epidemiol. 1998;8:272-277.